INCYTE CORPORATION vs IQVIA HOLDINGS INC., two Biotechnology stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where INCY and IQV diverge most: on debt / equity, INCY reads 0.00 and IQV reads 2.49; on implied growth (priced in), INCY reads +3.0% and IQV reads +21.4%. The rest of the comparable metrics sit closer together. On valuation, today's INCY price has a different growth bar priced in than IQV (+3.0% implied for INCY vs +21.4% for IQV); the higher figure is the steeper assumption to clear, not a better or worse stock. What INCY's price implies is a bet that sits within the historical range (whole-company basis). What IQV's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | INCY | IQV |
|---|---|---|
| Price | $119.47 | $235.13 |
| Market cap | $23.9B | $39.9B |
| Sector | Biotechnology | Biotechnology |
| Stage | Growth | Mature |
| Implied growth (priced in) | +3.0% | +21.4% |
| P/E | 16.9 | 29.2 |
| P/B | 4.24 | 6.29 |
| P/S | 4.45 | 2.40 |
| EV/EBITDA | 12.5 | 16.0 |
| Revenue growth | +21.3% | +7.3% |
| Operating margin | 23.7% | 12.4% |
| Net margin | 26.7% | 8.3% |
| Return on equity | 25.5% | 21.8% |
| Return on assets | 19.5% | 4.7% |
| Return on invested capital | 25.3% | 7.8% |
| FCF yield | 6.3% | 5.3% |
| Debt / equity | 0.00 | 2.49 |
| Current ratio | 3.68 | 0.75 |
| Altman Z (solvency) | 7.62 | 1.92 |
| Piotroski F (quality) | 6 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.